St Louis, Missouri
Microencapsulation & Continuous Granulation
St. Louis, Missouri, USA serves as Codis’ corporate headquarters and is built on decades of leadership in microencapsulation and continuous granulation. FDA-inspected and EU GMP-aligned, the site enables rapid manufacturing scale-up from laboratory to commercial volumes, with strong regulatory compliance and operational integrity.
Capabilities at a Glance
-
Microencapsulation
Proprietary solvent-free processes delivering actives and nutritional products with enhanced taste masking, stability, and controlled release.
-
Continuous Granulation
High-shear, continuous granulation tailored for tight particle size control and scalable performance in OSD formulations.
Quality, Compliance & Regulatory Assurance
This facility operates under stringent cGMP standards (21 CFR Parts 210/211, 110/111, 117). It has successfully passed multiple FDA inspections, most recently in 2025, underscoring its commitment to consistent regulatory excellence.

R&D-Driven Production
The St. Louis facility houses a full spectrum of pilot and commercial-scale equipment, enabling Codis to transition seamlessly from concept to product. Whether for custom granulation projects or tailored microencapsulation, the site supports both our proprietary product lines (e.g. Descote®, MicroMask®) and bespoke client formulations.
Discover Codis
Explore how Codis applies its expertise in spray drying, microencapsulation, continuous granulation, final dosage forms, and functional products to meet your formulation and manufacturing needs.
Codis Insights & Updates
Stay current with the latest in particle engineering science and Codis articles and resources.
Connect with us to explore how our particle engineering, commercial spray drying, formulation, and advanced manufacturing capabilities deliver high-quality, dependable supply for even the most challenging products.